AN INVITATION TO PARTICIPATE IN AN

INTERNATIONAL REGISTRY TO STUDY DAILY

& NOCTURNAL HEMODIALYSIS

 

The Frequent Dialysis Regimens Workgroup of the Lawson Health Research Institute (LHRI) in London, Ontario, Canada, has recommended an international registry as an important step in establishing the future role of daily (quotidion) dialysis regimens.

 

This initiative is endorsed by the U.S. National Institutes of Health (NIH), National

Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and the International Society for Hemodialysis (ISHD). The specific goals of the Registry are to:

 

1. evaluate a spectrum of outcomes both before and after switching from

conventional thrice-weekly hemodialysis (CHD) to quotidian dialysis.

 

2. conduct a matched cohort-control study using CHD patients registered in

the United States Renal Data System (USRDS) and the Canadian Organ

Replacement Register (CORR) as control subjects.

 

3. obtain data describing quotidian dialysis practices and associated outcomes

to assist in the development of new technologies and create practice

standards.

 

Prospective data will be collected on prevalent and incident patients. In addition

to demographic, comorbidity, and biochemical data, centers will be asked

to report endpoints such as hospitalization, death, modality change, and vascular

access problems.

 

All participating centers will have access to their own patient- and center-specific

data, as well as pooled-data reports.

 

Any centers prescribing dialysis regimens, with a frequency of five or more

treatments per week, are welcome to enroll and can obtain further information

by sending a request by email to: info@quotidiandialysis.org or fax 519.685.8395.

 

ROBERT M. LINDSAY, MD, FRCPC, FRCPE, FACP • GIHAD NESRALLAH, MD, FRCPC, FACP •

FREQUENT DIALYSIS REGIMENS WORKGROUP • THE UNIVERSITY OF WESTERN ONTARIO •

LONDON HEALTH SCIENCES CENTRE • LONDON, ONTARIO, CANADA